© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Pluronic F 127, also known as Poloxamer 407, stands out as a product born from decades of polymer science. Its origins trace back to the mid-20th century, a time when chemists first worked out how to connect oxyethylene and oxypropylene blocks in a controlled fashion. In those early years, innovation in nonionic surfactants met real-world needs for stable emulsifiers and solubilizers. Research in the 1970s and 80s brought Pluronic F 127 into laboratories and industries hungry for reliable phase-changing polymers. The patent filings and initial studies shaped a path that's taken Pluronic from bench chemistry all the way to clinical trials and everyday consumer products.
Pluronic F 127 attracts attention for more than one reason. Its block copolymer structure gives it a set of characteristics rarely found together: water solubility, low toxicity, and a knack for forming gels at body temperature. In practice, this means formulators reach for Pluronic F 127 when faced with the challenge of mixing hydrophobic and hydrophilic substances. Pharmacies, personal care brands, and medical researchers rely on it to create creams, injectable gels, and even controlled drug delivery systems. Chemically, Pluronic F 127 brings flexibility without burdening users with safety trade-offs.
Solid at room temperature, this white, waxy poloxamer transforms upon mixing with water. It dissolves smoothly, creating a clear solution that turns into a gel as temperatures rise around 20–25°C. This shift, called thermoreversible gelation, comes from the balance between hydrophilic and hydrophobic interactions in its structure. Each molecule consists of a central block of polyoxypropylene, flanked by polyoxyethylene. These ends favor water, the center repels it, and together they self-assemble at the right temperature or concentration. The molecular weight often ranges from 12,000 to 14,000 g/mol, lending structure while keeping the substance easy to handle.
Suppliers commonly label Pluronic F 127 with its INCI name (Poloxamer 407) and an identifying code for lot consistency. They report composition, appearance, molecular weight distribution, and residual solvents, ensuring manufacturers know exactly what they’re getting. Product datasheets include gelation temperature, viscosity curves, and concentration guidelines. Transparency about these parameters protects product quality across pharmaceuticals, biotechnologies, and cosmetic applications. Proper labeling not only aids the end-user but fulfills regulatory mandates in regions like Europe and North America.
Production often relies on stepwise polymerization, first assembling a hydrophobic core of propylene oxide onto an initiator, followed by capping with ethylene oxide to form the hydrophilic blocks. Manufacturers control reaction temperature, pressure, and timing to tune molecular weight and block ratio. Each batch undergoes purification to strip free monomers and solvents, often utilizing distillation or filtration. The final product comes as a powder or flakes, stable under dry, cool storage conditions, and ready for dispersion in water or buffer solutions.
Pluronic F 127’s backbone supports simple and more complex modifications. Reaction with aldehydes, acids, or isocyanates can introduce reactive groups for specific targeting or cross-linking. Scientists attach drugs, peptides, or other moieties to these sites for improved delivery or sustained release. Sometimes, blending with other polymers amplifies the mechanical or thermal properties. In tissue engineering, for example, Pluronic F 127 forms injectable hydrogels that set rapidly yet allow cell infiltration. Such versatility springs from accessible hydroxyl groups at the polymer ends, enabling creative chemistry for tailored outcomes.
Besides the familiar name Pluronic F 127, this surfactant appears as Poloxamer 407, Lutrol F 127, Kolliphor P 407, and Synperonic PE/F 127 across catalogs and safety sheets. Manufacturers often incorporate specific branding or quality grades, such as ‘pharmaceutical grade’ or ‘ultra-pure’. Understanding these synonyms prevents sourcing mishaps and keeps supply chains running smoothly, especially for critical pharmaceutical or medical device makers.
Long-term research points to a favorable safety profile for Pluronic F 127. Extensive animal tests and clinical studies demonstrate minimal skin, eye, or mucous membrane irritation at recommended concentrations. Regulatory authorities such as the FDA and EMA list Poloxamer 407 as generally recognized as safe (GRAS) for many uses. Handling still requires basics: goggles to prevent eye contact with powders, gloves to minimize skin exposure, and dust control in production settings. Waste streams from synthesis receive careful management to avoid releasing unreacted monomers or solvents. In regular practice, Pluronic F 127 finds a place in closed manufacturing systems that reduce exposure risks for workers and end users alike.
Rarely does a surfactant see such diverse applications. The pharmaceutical industry turns to Pluronic F 127 in topical gels, dental pastes, and injectable drug carriers. These gels can deliver drugs directly to affected sites, reducing the burden on the whole body. Ophthalmology benefits from slow-release eye drops, while dermatology uses them for wound healing agents. Cosmetics outfits use Pluronic F 127 to stabilize creams and lotions, giving customers products that feel light yet hydrate deeply. In research, Pluronic F 127 helps to grow cells on inert scaffolds or deliver genes to animal models. The detergent and cleaning industries shape it into specialty cleaners for sensitive electronics and medical devices. Each field builds upon different aspects of Pluronic F 127’s chemistry — its switching solubility, ability to encapsulate actives, and biocompatibility.
Current research sees a steady stream of articles exploring how to stretch the limits of Pluronic F 127. Teams around the globe test combinations of the surfactant with other polymers and nanoparticles for targeted drug delivery. A big draw here is Pluronic’s thermogelation, which lets doctors inject liquids that turn solid right in the body, then slowly release medicine. Hospital labs trial new wound care gels with anti-inflammatory or antibacterial agents, hoping to improve healing outcomes. COVID-19 renewed interest in vaccines, with Pluronic F 127 used as part of the nanoparticle carriers that safely introduce genetic material into cells. These projects build credibility for the surfactant’s adaptability, buoyed by positive results in animal and human trials.
Years of studies offer detailed reports about Pluronic F 127’s interaction with living systems. Researchers track acute and chronic effects, metabolism, and elimination. Repeated dosing in animal models at high concentrations brings mild gastrointestinal effects and slight changes in fatty tissue, usually reversible. No links to mutagenicity or genotoxicity surface at application-relevant doses. Human studies in both healthy volunteers and patient groups confirm these findings, pointing to a broad safety window. Monitoring continues as new uses emerge—the pharmaceutical sector, in particular, emphasizes regular toxicity screenings to make sure formulations remain as safe as their individual ingredients.
The future for Pluronic F 127 looks promising as healthcare moves toward more tailored and less invasive treatments. Real breakthroughs may lie in smart gels that respond to pH or other triggers, releasing drugs only where needed. Tissue engineers imagine scaffolds that help organs heal enough to avoid transplants. Sustainable manufacturing could drive further refinement, swapping out petrochemical feedstock for bio-based alternatives. With new analytical tools, researchers learn even more about the micro- and nanoscale behavior of Pluronic F 127, powering innovations in controlled delivery, imaging, and even regenerative medicine. Companies ready to invest in quality and transparency will set the standard.
Pluronic F-127 falls into the family of poloxamers, which are synthetic block copolymers made by linking polyethylene oxide with polypropylene oxide. It's a white, free-flowing powder at room temperature, but that doesn't say much about why people care about it. This material shows a special property: its solutions behave like a liquid when cold, but turn into a gel once they hit body temperature. In practical terms, this allows researchers and companies to take advantage of that temperature switch in the lab and in medicine.
A few years back, I worked with a team designing better ways to deliver medicine to hard-to-reach parts of the body. We tried several carriers, but kept returning to Pluronic F-127. Most drugs get washed away or degraded by the body before reaching their target, especially if injected or applied topically. Pluronic F-127 forms gels that stick around long enough for drugs to seep out slowly. That’s a big deal for anything from delivering local anesthesia to helping wounded tissue heal.
Doctors often use it to suspend antibiotics or chemotherapy agents directly at the treatment site. Scientists saw that mixing cells or proteins with Pluronic F-127 makes it easier to study how they behave in 3D structures—critical for tissue engineering. Its gel-forming feature helps create scaffolds that mimic real tissue, supporting cells as they grow and organize. This approach keeps showing promise for wound healing and lab-grown organs or cartilage.
Even big pharmaceutical companies rely on Pluronic F-127 when designing better creams, ointments, and eye drops. Its ability to turn into a gel at human body temperature protects sensitive drugs, prevents them from being flushed away, and gives treatments more time to work. For eye care, traditional eye drops wash away too quickly, especially after blinking. Gels based on Pluronic F-127 stick around much longer, which can boost comfort and effectiveness for people with chronic dry eyes or those recovering from surgery.
Many scientists trust Pluronic F-127 because it shows almost no toxicity when tested on cells or used in animals. The FDA has recognized this material as safe for certain uses, which removes obstacles when moving from lab testing to real treatments. This status does not come easy; many synthetic polymers fail safety tests, but Pluronic passes because the body breaks it down into harmless pieces.
While Pluronic F-127 serves science well, it's not without issues. Some drugs won’t dissolve well in its gel. Also, since the human body is unpredictable, temperature triggers don’t always act the same in different people. Room for improvement remains—researchers are experimenting with mixing in other materials to give gels more strength or tailor how fast they release drugs.
Lately, I've noticed more interest in using Pluronic F-127 beyond medicine. Some engineers see potential in 3D printing, where its unique gelation could shape new structures layer by layer. Others look to it for cosmetic or personal care products, where smooth texture and stability matter. The science keeps moving, and Pluronic F-127 keeps showing up as a key tool in the toolkit.
Pluronic F 127 has earned a spot in labs and clinics, especially for its track record as a smart polymer. This block copolymer, made from polyethylene oxide and polypropylene oxide, brings special chemistry to the table that turns liquid solutions into gels at the right temperature. Anyone who has wrestled pipettes in a chilly fridge knows: getting this stuff mixed and handled correctly makes all the difference between smooth science and frustrating mess.
Whenever people whip up a batch of Pluronic F 127, the most common move is to add the powder slowly to cold water—straight from the fridge, typically 2–8°C. It clumps and floats if rushed, so most researchers let it sit overnight with gentle stirring. Solutions above 20% weight/volume really test that patience, since this material thickens fast. Some tilt their bottles or use magnetic stir bars to speed things along, but try to avoid heavy-duty blenders. Vigorous mixing can heat up the solution. Once it crosses 15°C or so, the polymer starts gelling and there’s no turning back.
Proper handling doesn’t end at mixing. Light, humidity, and—especially—heat can all shift Pluronic F 127’s performance. I remember one summer I left a batch at room temperature; it set like Jell-O and splitting it back into solution became impossible. Reliable work needs repeatability; that’s where strict storage steps come in. Powder stays in sealed, light-blocking containers, tucked in at 2–8°C. Open bottles suck in water from the air and clump up, so only scoop what you’re sure you’ll use that day.
With solutions, keep them sealed tight. An old glass bottle with a ground-glass stopper works well because it prevents evaporation. Stick with the same cold fridge (never the freezer; crystals ruin consistency on thawing). Used solutions often lose sterility after a few days, so most researchers treat new batches like perishables: label, date, and don’t use past a week unless you can guarantee the sterility.
Biggest pitfall comes from rushed preparation or underestimating contamination. Pluronic F 127 feeds bacteria and molds if left out too long or if a soiled instrument dips in. A single pipette tip can spoil a whole bottle. This is not only a headache for reproducibility—sterile filtration or autoclaving (if the system allows) should be the norm for sensitive applications, like drug delivery or tissue engineering. I’ve seen promising results slip away because a team didn’t build this routine into their workflow.
Lab culture shapes how people use Pluronic F 127. Seasoned teams label everything, follow checklists for cleaning, and train newcomers to respect temperature changes. Even in busy clinics, pharmacy techs working with this polymer for topical gels follow time-tested cold chain protocols like those used for vaccines. Experienced scientists keep powder stocks small and refresh solutions often, instead of scaling up all at once.
There’s room to share results and mistakes among groups in biotech, academia, or clinics. Regular workshops on best practices for polymers like Pluronic F 127—covering mixing, storage, and contamination control—go a long way in keeping experiments reliable and safe. A commitment to detail, not shortcuts, keeps this handy polymer ready for real scientific work.
Working in labs over the years, I’ve come across a bunch of substances that claim to be indispensable for drug delivery or tissue engineering. Pluronic F 127 is one of those names you hear tossed around in formulations and cell culture when people want temperature-sensitive gelling. It’s got this cool trick—becoming a liquid at low temperatures and turning into a gel near body temperature. For designing injectable drugs or 3D cell cultures, this characteristic attracts researchers and companies.
Pluronic F 127 belongs to a group called block copolymers. At its core, it’s made of repeating units of polyethylene oxide and polypropylene oxide. The structure seems harmless, but questions about safety never fade—especially when a product interacts with cells, tissues, or enters the human body. It's a smart move to ask whether this gel could cause irritation or toxicity down the line.
Data from both animal and cell studies show Pluronic F 127 rarely triggers toxicity at normal concentrations. Cell cultures exposed to it have demonstrated good viability, with exceptions at very high doses, where cell damage pops up. The numbers back up its safety at the concentrations usually used in research—often between 0.1% and 30% w/v, depending on the scenario.
A decade of preclinical animal work supports this claim. For example, gels injected under the skin in rats or rabbits often show minimal immune reaction or inflammation. Old FDA filings and published literature suggest it doesn’t build up in organs and the body clears it pretty efficiently. Still, stuff changes when scaling up from mice to humans, so keeping an eye on long-term effects remains important.
Doctors and pharmacists see Pluronic F 127 in wound dressings, eye drops, and topical products. Most patients tolerate it well, though sensitive individuals sometimes report itching or mild swelling. In rare cases, allergic responses pop up—not ideal, but no worse than other synthetic agents. Beyond the usual mild symptoms, few severe side effects get reported in the literature. Long-term or cumulative effects just haven’t been seen in large, well-controlled human studies.
One ongoing concern: purity and consistency. Industrial-grade Pluronic often carries trace chemicals from the production process, so pharmaceutical makers must demand medical- or research-grade material, tested for endotoxin and other contaminants. Skipping those steps can leave patients open to risk—not from the product itself, but from something that sneaks in during manufacturing.
Letting researchers and clinicians share real-world feedback stands out as a way to spot rare complications early. Pharmaco-vigilance, not just in clinical trials but after commercial launch, gives regulators the power to catch trouble before it spreads. Publishing all data, including negative findings, means we can see the full story—not just sales pitches from suppliers.
At the bench, safer handling means careful dosing, proper material sourcing, and thoughtful clean-up after spills. For anyone developing therapies, always trace the Pluronic F 127 lot back to a trusted supplier and review their latest independent toxicology results. Scientists owe the public full transparency, not just about spectacular results, but about risks and how they're being managed.
Any scientist who’s worked with Pluronic F 127 knows the routine: tear open the powder, eyeball the glossy white flakes, and then get sucked into the vortex of concentration choices. Sometimes it feels like everyone in the lab uses a different amount because the polymer’s flexibility winds up creating more questions than answers. But a few concentrations keep popping up in published work and under the microscope. Here’s what I’ve seen and learned in years of handling this stuff in cell experiments and gel applications.
In cell culture and drug delivery labs, Pluronic F 127 usually gets pegged between 10% and 30% weight/volume for gelation. At 20%, you get a sweet spot: clear gel at room temperature, but manageable liquid from the fridge. This concentration comes up over and over for cell encapsulation, especially with soft tissues. Try going below 15%, it starts flowing instead of forming a sturdy scaffold. Push above 30%, and you get stiffness but lose injectability—plus, pipetting turns into a forearm workout.
I remember the first time someone in my group wanted to grow neural stem cells in a 5% F 127 gel. We tried it, but the solution stayed runny at body temperature. That batch went straight to the waste bin, along with my patience for low concentrations. Between 15% and 25%, the transition temperature matches body heat, which gives a practical window for mixing in cells or drugs, then watching the solution gel up right where you want it.
This versatile polymer shines because its hydrophilic and hydrophobic blocks form micelles that lock together at the right temperature. Get the concentration wrong, and the thermogelling magic fizzles out. Several papers I’ve dug through point to a lower limit near 5% for normal solubility, but gelation usually needs a good deal more. One high-impact Nature article reported that human mesenchymal stem cells survived best around 17%—enough structural support without choking off nutrient diffusion.
Researchers mixing in signaling molecules or nanoparticles often land in the 15-25% world too. These concentrations let additives stay suspended without falling out or clumping, especially for local drug delivery. In wound dressings, 20% shows up as the sweet spot for staying stuck to tissue but still releasing drugs at a steady rate.
Picking the right concentration isn’t just about stability. Budget and source shake things up too. Even slight purity variations in stock F 127 skew gel points a couple of degrees, especially with off-brand powders. Some researchers toss in salts or load cells too dense, bumping up viscosity headaches. Plus, lab temperatures rarely stay steady through the day, which can throw off results if you’re not paying attention. I’ve seen more than one undergrad swearing at opaque gels that turned runny in morning lab, but set like concrete by the afternoon. They learn fast: always watch the thermometer.
Good science means sharing real numbers, not just “we used F 127.” Everyone in the lab should titrate batches and actually measure gel points, not just trust the internet or the guy down the hall. Keeping tight records of which batch and supplier helped my team cut out sticky surprises. Sticking with the proven 15-25% range covers most bases, but it always pays to double-check before scaling up. And if I see a new paper reporting results with “F 127, unspecified,” my confidence drops fast. If you want reproducible results, concentration transparency isn’t optional—it’s the foundation.
Pluronic F 127, also called poloxamer 407, gets plenty of use in labs, the pharmaceutical world, and even in personal care products. People working with it often ask about how long it keeps and what to do with leftovers. It's become routine to see this white, waxy powder around research benches and formulation rooms. Knowing how it breaks down and how to toss it out safely matters for everyone’s routine and the environment.
The solid, unopened form of Pluronic F 127 usually lasts about two to three years if stored right. A sealed container, kept dry and out of strong sunlight, preserves its quality. Pluronic F 127 loves to soak up moisture, so leaving it exposed to air just means it might clump or spoil faster.
I’ve seen old containers tucked away in temperature-controlled cabinets, sometimes outliving what the label recommends, but the guarantee for top performance tends to stick at the two-to-three-year mark. Once a package gets opened, the clock ticks a little faster, especially if it sits near a humid sink or gets handled without care. Different suppliers might list different periods on their labels, so reading those notes helps keep everything safe and predictable.
Pluronic F 127 stays in good shape inside a tightly sealed container, parked in a cool, dry place. Most labs use desiccators to avoid the powder grabbing moisture from the air. Liquid solutions need refrigeration if they sit more than a few days—toss any mix that’s cloudy or smells odd.
Hands-on experience taught me the dangers of ignoring storage—one spilled bag spoiled a month’s work and showed up in every new sample I made. Sterile technique and the right container pay off with less waste and less frustration, every time.
Disposing of a chemical like Pluronic F 127 never means just tossing it down the drain or into regular trash cans. It’s not a hazardous waste on its own, but the company that picked up our lab's unused batches took it with other non-hazardous chemicals to a licensed waste site. If it’s mixed with other materials, those ingredients might change the rules.
Some facilities recycle containers; others direct users to wash out small amounts with lots of running water, making sure the powder dissolves. Following local laws and environmental safety rules always made sense—both in academic and industry settings where I’ve worked. Safety data sheets provide the best rundown for your company or school, and it’s smart to check with the on-site environmental health team before taking shortcuts.
Careful storage and disposal don't just protect experiments, they help schools, companies, and communities avoid spills or environmental headaches. I’ve watched teams lose time, money, and equipment through simple mistakes involving containers or careless waste. Investing in training, using proper signage, and making sure old stock gets sorted at least once a year protects everyone.
Every lab or production floor has to balance routine work with thoughtful stewardship. By looking after how we store and discard common chemicals like Pluronic F 127, we protect results, people, and the spaces we depend on.
| Names | |
| Preferred IUPAC name | Poly(oxyethylene)-poly(oxypropylene)-poly(oxyethylene) block copolymer |
| Other names |
Poloxamer 407 Pluronic F-127 Pluronic F127 Synperonic PE/F 127 Poloxalene Pluronic PF127 Pluronic 127 Kolliphor P407 Lutrol F127 |
| Pronunciation | /əˈxen̪.te ðe supeɾˈfi.θje pluˈɾo.nik ɛf ˈsjɛtɛ/ |
| Identifiers | |
| CAS Number | 9003-11-6 |
| 3D model (JSmol) | `3D structure; CA(CO)(CO)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC(COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)O` |
| Beilstein Reference | 3947217 |
| ChEBI | CHEBI:53558 |
| ChEMBL | CHEMBL271313 |
| ChemSpider | 86814632 |
| DrugBank | DB06831 |
| ECHA InfoCard | 100.116.869 |
| EC Number | 9003-11-6 |
| Gmelin Reference | 6840 |
| KEGG | C06043 |
| MeSH | D005571 |
| PubChem CID | 24888114 |
| RTECS number | MU1053000 |
| UNII | 97572JIK5A |
| UN number | UN3082 |
| Properties | |
| Chemical formula | (C3H6O·C2H4O)x |
| Molar mass | 12600 g/mol |
| Appearance | White, waxy, free-flowing granules |
| Odor | Odorless |
| Density | 1.02 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -2.1 |
| Vapor pressure | Negligible |
| Basicity (pKb) | 14.7 |
| Magnetic susceptibility (χ) | -9.05 x 10^-6 cm³/mol |
| Refractive index (nD) | 1.090 |
| Viscosity | Gel (31500 - 45000 CPS a 25°C) |
| Dipole moment | 0.00 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 132.8 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | A06AD15 |
| Hazards | |
| Main hazards | Not hazardous according to GHS classification. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H315: Causes skin irritation. H319: Causes serious eye irritation. |
| Precautionary statements | Precautionary statements: P264, P305+P351+P338 |
| NFPA 704 (fire diamond) | 1-0-0-W |
| Flash point | > 107°C |
| LD50 (median dose) | > 7,500 mg/kg (oral, rat) |
| NIOSH | RX8345000 |
| REL (Recommended) | 10-200 mg/L |
| Related compounds | |
| Related compounds |
Poloxamer 188 Poloxamer 407 PEG-PPG-PEG copolymer Pluronic F68 Poloxamer 338 Pluronic L44 Poloxamer 234 |
